semaglutide and chronic kidney disease Semaglutide: A New Era in Health Semaglutide in patients with overweight

Haemochromatosis Treatment

Though the exact mechanisms driving stimulant-associated cardiomyopathy are unknown, myocardial injury is thought to be related to excess catecholamines and the generation of reactive oxygen species, mitochondrial dysfunction, and the downstream effects of microvascular dysfunction and vasospasm

Pharmaceuticals 14, 4

How Tirzepatide Works: Similar to Semaglutide, Tirzepatide reduces appetite and food intake, but with the added benefit of GIP stimulation, which further enhances insulin secretion and fat metabolism

T3 also increases hepatic gluconeogenesis by increasing activity of phosphoenolpyruvate carboxykinase (PEPCK), an enzyme that enhances gluconeogenesis [17,18]